Furthermore, IHC staining using γH2AX showed that DNA damage in tumor lesions, which was increased by YY2 overexpression or oxaliplatin treatment alone, was further enhanced by combined oxaliplatin treatment and YY2 overexpression (Figure S11F, Supporting Information). This evidence concerns the gene YY2 and neoplasm.